Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events